Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)Products & Services: a) Stem Cell R&D: Stem Cell Research & Therapy, Regenerative Medicine, Bio-artificial organ scaffolds development, nano-biotechnology, Nano-formulation of cancer Drugs, Molecular genetics, and Molecular virology, Stem cell and Cord blood banking...
Samsrita Labs has announced the publication of its un-audited financial results for the quarter ended 30th June, 2026. The Board of Directors approved these results in a meeting on August 13. Investors can find the complete standalone and consolidated financial results, including a quick response code, on the company's website...
Scrutinizer''s Report for the 30th AGM held on 10.08.2026
Outcome of 30th Annual General Meeting held on 10.08.2026
Samsrita Labs Limited has announced its 30th Annual General Meeting (AGM) for FY 2025-26, which will be held on Monday, August 10, 2026, at 11:00 A.M. via Video Conference/Other Audio-Visual Means. Electronic copies of the AGM notice and Annual Report were sent to shareholders on July 18, 2026. Shareholders can...
Samsrita Labs has announced the publication of the notice for its 30th Annual General Meeting. The AGM is scheduled for August 10th, 2026, at 11:00 AM. Shareholders can attend the meeting virtually via Video Conference/Other Audio-Visual Means. This notice, providing details about the crucial annual gathering, was published in Financial...
